Table 3.
Molecules and pathways involved in apoptosis in TMJ OA.
| Main Factors | Pathways | Effect on Apoptosis | References |
|---|---|---|---|
| LncRNA PVT1 | – | Aggravation | 63 |
| LncRNA HOTAIR | – | Aggravation | 20 |
| CircRNA GCN1L1 | – | Aggravation | 64 |
| miR-15b | – | Aggravation | 65 |
| miR-101a-3p | – | Aggravation | 66 |
| mTORC1 | – | Aggravation | 67 |
| β-catenin | Wnt/β-catenin | Aggravation | 68 |
| Ihh | Ihh | Aggravation | 69 |
| p21 | – | Inhibition | 37 |
| Smad3 |
|
Inhibition | 52 |
| Mettl3 | m6A/Ythdf1/Bcl2 | Inhibition | 70 |
Abbreviations: mTORC: mammalian target of rapamycin complex; EIF2AK3: ukaryotic translation initiation factor 2 alpha kinase 3; TGF-β: transforming growth factor beta; S1P: sphingosine-1-phosphate; mettl3: m6A regulators like methyltransferase-like 3; Ythdf1: YT521-B homology (YTH) domain-containing proteins 1; m6A: N6-methyladenosine.